Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical doxepin versus standard treatment for post-burn pruritus
NL-OMON39365Recruiting
- Sponsor
- Association of Dutch Burn Centres
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in pruritus and burn injury comparing Doxepin cream arm with Clemastine standard treatment arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Dec 2013; status: recruiting.
02
Drugs
doxepinclemastine
03
Conditions
pruritusburn injury
Beyond the preview
Go deeper on NL-OMON39365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39365.